These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 31456471)

  • 21. Guest Editor John Cooke Offers Expertise and Insight on Nanotherapeutic Solutions for Cardiovascular Diseases.
    Methodist Debakey Cardiovasc J; 2016 Sep; 12(3):131. PubMed ID: 27826364
    [No Abstract]   [Full Text] [Related]  

  • 22. Targeted, triggered drug delivery to tumor and biofilm microenvironments.
    Benoit DS; Koo H
    Nanomedicine (Lond); 2016 Apr; 11(8):873-9. PubMed ID: 26987892
    [No Abstract]   [Full Text] [Related]  

  • 23. Novel nanoparticulate drug delivery systems.
    Friedrich RP; Pöttler M; Cicha I; Lyer S; Janko C; Alexiou C
    Nanomedicine (Lond); 2016 Mar; 11(6):573-6. PubMed ID: 26911384
    [No Abstract]   [Full Text] [Related]  

  • 24. Functionalized gold nanoparticles for drug delivery.
    Han G; Ghosh P; Rotello VM
    Nanomedicine (Lond); 2007 Feb; 2(1):113-23. PubMed ID: 17716197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nanoparticle-Mediated Drug Delivery for the Treatment of Cardiovascular Diseases.
    Pala R; Anju VT; Dyavaiah M; Busi S; Nauli SM
    Int J Nanomedicine; 2020; 15():3741-3769. PubMed ID: 32547026
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expanding the therapeutic potential of statins by means of nanotechnology enabled drug delivery systems.
    Romana B; Batger M; Prestidge CA; Colombo G; Sonvico F
    Curr Top Med Chem; 2014; 14(9):1182-93. PubMed ID: 24678704
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Engineered nanoparticles for drug delivery in cancer therapy.
    Sun T; Zhang YS; Pang B; Hyun DC; Yang M; Xia Y
    Angew Chem Int Ed Engl; 2014 Nov; 53(46):12320-64. PubMed ID: 25294565
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nanoparticles: crossing barriers and membrane interactions.
    Puri A
    Mol Membr Biol; 2010 Oct; 27(7):213-4. PubMed ID: 20929338
    [No Abstract]   [Full Text] [Related]  

  • 29. The physiology of cardiovascular disease and innovative liposomal platforms for therapy.
    Ruiz-Esparza GU; Flores-Arredondo JH; Segura-Ibarra V; Torre-Amione G; Ferrari M; Blanco E; Serda RE
    Int J Nanomedicine; 2013; 8():629-40. PubMed ID: 23413209
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A novel approach for establishing cardiovascular drug efficacy.
    Heerspink HJ; Grobbee DE; de Zeeuw D
    Nat Rev Drug Discov; 2014 Dec; 13(12):942. PubMed ID: 25398246
    [No Abstract]   [Full Text] [Related]  

  • 31. Unmet needs in developing nanoparticles for precision medicine.
    Schwartz S
    Nanomedicine (Lond); 2017 Feb; 12(4):271-274. PubMed ID: 28093937
    [No Abstract]   [Full Text] [Related]  

  • 32. The European project NanoAthero to fight cardiovascular diseases using nanotechnologies.
    Chauvierre C; Letourneur D
    Nanomedicine (Lond); 2015 Nov; 10(22):3391-400. PubMed ID: 26582278
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stimuli-responsive polymeric nanoparticles for nanomedicine.
    Crucho CI
    ChemMedChem; 2015 Jan; 10(1):24-38. PubMed ID: 25319803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thermo-responsive fibrinogen nanogels: a viable thermo-responsive drug delivery agent for breast cancer therapy?
    Sreerenganathan M; Mony U; Rangasamy J
    Nanomedicine (Lond); 2014 Dec; 9(18):2721-3. PubMed ID: 25535683
    [No Abstract]   [Full Text] [Related]  

  • 35. Fabrication of Cellulose-Nanocrystal-Based Folate Targeted Nanomedicine via Layer-by-Layer Assembly with Lysosomal pH-Controlled Drug Release into the Nucleus.
    Li N; Zhang H; Xiao Y; Huang Y; Xu M; You D; Lu W; Yu J
    Biomacromolecules; 2019 Feb; 20(2):937-948. PubMed ID: 30621397
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Prolonged therapy problems in cardiovascular diseases].
    Mazur NA
    Kardiologiia; 1979 Oct; 19(10):5-9. PubMed ID: 116054
    [No Abstract]   [Full Text] [Related]  

  • 37. Nanomedicine: sizing up targets with nanoparticles.
    Minchin R
    Nat Nanotechnol; 2008 Jan; 3(1):12-3. PubMed ID: 18654442
    [No Abstract]   [Full Text] [Related]  

  • 38. Heart targeted nanoliposomal/nanoparticles drug delivery: An updated review.
    Cheraghi M; Negahdari B; Daraee H; Eatemadi A
    Biomed Pharmacother; 2017 Feb; 86():316-323. PubMed ID: 28011379
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nanomedicine for drug delivery and imaging: a promising avenue for cancer therapy and diagnosis using targeted functional nanoparticles.
    Liu Y; Miyoshi H; Nakamura M
    Int J Cancer; 2007 Jun; 120(12):2527-37. PubMed ID: 17390371
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vitamin E TPGS-emulsified poly(lactic-co-glycolic acid) nanoparticles for cardiovascular restenosis treatment.
    Feng SS; Zeng W; Teng Lim Y; Zhao L; Yin Win K; Oakley R; Hin Teoh S; Hang Lee RC; Pan S
    Nanomedicine (Lond); 2007 Jun; 2(3):333-44. PubMed ID: 17716178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.